Avidity Biosciences (RNA) Return on Equity: 2020-2025
Historic Return on Equity for Avidity Biosciences (RNA) over the last 5 years, with Sep 2025 value amounting to -0.36%.
- Avidity Biosciences' Return on Equity fell 15.00% to -0.36% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.36%, marking a year-over-year decrease of 15.00%. This contributed to the annual value of -0.33% for FY2024, which is 6.00% up from last year.
- As of Q3 2025, Avidity Biosciences' Return on Equity stood at -0.36%, which was up 1.19% from -0.36% recorded in Q2 2025.
- Avidity Biosciences' 5-year Return on Equity high stood at -0.21% for Q3 2024, and its period low was -0.43% during Q3 2022.
- In the last 3 years, Avidity Biosciences' Return on Equity had a median value of -0.34% in 2024 and averaged -0.32%.
- Per our database at Business Quant, Avidity Biosciences' Return on Equity dropped by 17bps in 2021 and then climbed by 20bps in 2024.
- Over the past 5 years, Avidity Biosciences' Return on Equity (Quarterly) stood at -0.30% in 2021, then dropped by 6bps to -0.36% in 2022, then declined by 5bps to -0.42% in 2023, then increased by 20bps to -0.22% in 2024, then dropped by 15bps to -0.36% in 2025.
- Its Return on Equity stands at -0.36% for Q3 2025, versus -0.36% for Q2 2025 and -0.27% for Q1 2025.